HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LF 1695

structure given in first source

Also Known As:

2-(4-methyl-1-piperidinyl)-5-aminophenyl-(4-chlorophenyl)methanone; LF-1695

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - LF 1695: 2

Related Diseases

1.	AIDS-Related Complex (ARC) 01/01/1989 - "After investigations of LF 1695 effect on HIV-infected cells, clinical trials have been initiated in AIDS and ARC patients."
2.	Acquired Immunodeficiency Syndrome (AIDS) 01/01/1989 - "After investigations of LF 1695 effect on HIV-infected cells, clinical trials have been initiated in AIDS and ARC patients."
3.	Schistosomiasis (Bilharziasis) 01/01/1988 - "In vitro and in vivo immunomodulation by LF 1695 of human and rat macrophages and platelets in schistosomiasis."
4.	Infections 01/01/1988 - "Finally, the oral treatment of rats with LF 1695, in the course of an experimental infection with schistosome parasites, induced a higher degree of immune protection (80%) against a challenge infection than untreated, infected control rats (40%). "

Related Therapies and Procedures

1.	Immunomodulation